[10] [14] According to their respective SmPCs, dizziness is classified as an 'uncommon' side effect for both Wegovy and Saxenda, meaning it may affect up to 1 in 100 people
The program also provides educational materials on how to maintain healthy blood pressure levels, empowering individuals with the knowledge they need to act early
Another study, using dulaglutide, reported a medium-to-large effect size for reducing alcohol use in people with obesity, although no benefit was seen in heavy drinkers [35]
The prospect of tens of millions of Americans slashing their daily intake to about 1,000 calories per day typical for GLP-1 users has obvious potential to unsettle consumer packaged goods (CPG) leaders, PwC said
The key takeaways from the study include: A significant reduction in the total amount of alcohol consumed
doi: 10.1371/journal.pone.0126003 40 AngelidiAMFilippaiosAMantzorosCS